Back to Clinical Trials Overview

Your search for "Brain" returned 44 results:


White Matter Abnormalities in the Schizophrenia Spectrum
Principal Investigator(s): Erin Hazlett

The WEB® Intrasaccular Therapy Study (WEB-IT)
Principal Investigator(s): J Mocco

A phase 1/2 Trial assessing the safety and efficacy of bilateral intraputaminal and intranigral administration of cere-120 (adeno-associated virus serotype 2 (AAV2)-Neirturin (NTN) in subjects with Idiopathic Parkinson's disease
Principal Investigator(s): Cho, Catherine

Objective and Subjective Measures of Cognitive Fatigue in Traumatic Brain Injury
Principal Investigator(s): Melissa Paretsky

A Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of MK-8931 in Subjects with Mild to Moderate Alzheimer's Disease (EPOCH)
Principal Investigator(s): Judith Neugroschl

Biomarkers of primary focal dystonias: structural-functional interactions
Principal Investigator(s): Kristina Simonyan

ACE: An Aneurysm Coiling Efficiency Study of the Penumbra Coil 400 System
Principal Investigator(s): Henry Moyle

POSITIVE: Perfusion Imaging Selection of Ischemic Stroke Patients for Endovascular Therapy
Principal Investigator(s): J Mocco

The BARREL Study - Prospective Multi-Center Single-Arm Study of the Reverse Medical Barrel™ VRD for Adjunctive Treatment to Embolic Coils for Wide-neck, Intracranial, Bifurcating/Branching Aneurysms of Middle Cerebral and Basilar Arteries
Principal Investigator(s): Johanna Fifi

The Manhattan HIV Brain Bank
Principal Investigator(s): Morgello, Susan

Recovery from Neurologic Deficits Caused by Spine Pathology
Principal Investigator(s): John Caridi

Protocol H8A-MC-LZAZ(a)/ADC-040-A4 Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Principal Investigator(s): Mary Sano

An fMRI Study of the Enhancement of Emotion Regulation in Borderline Patients
Principal Investigator(s): Harold W. Koenigsberg

Guanfacine Enhancement of Working Memory: Prospects for Augmenting Cognitive Remediation in the Schizophrenia Spectrum
Principal Investigator(s): Margaret McNamara-McClure

Management of Post-TBI Fatigue with Light Exposure
Principal Investigator(s): Jason Krellman

The Penumbra Liberty Trial: Safety and Effectiveness in the Treatment of Wide-Neck Intracranial Aneurysms
Principal Investigator(s): Henry Moyle

Imaging Genetics of Spasmodic Dysphonia
Principal Investigator(s): Kristina Simonyan

Futility Study of Deferoxamine Mesylate in Intracerebral Hemorrage (iDEF Trial)
Principal Investigator(s): Neha Dangayach

Neuroprotection in Patients Undergoing Aortic Valve Replacement
Principal Investigator(s): Annetine Gelijns

LARGE Aneurysm Randomized Trial: Flow Diversion Versus Traditional Endovascular Coiling
Principal Investigator(s): J Mocco

COAST: Coiling of Aneurysms Smaller Than 5mm With HyperSoft®
Principal Investigator(s): J Mocco

An Exploratory Phase II Study to Determine the Safety and Tolerability and activity of a Novel Vasopressin 1a Receptor Antagonist in Adults with DSM-5 Intermittent Explosive Disorder (IED)
Principal Investigator(s): Antonia S. New

Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response
Principal Investigator(s): Kristina Simonyan

A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Deep Transcranial Magnetic Stimulation (DTMS) for the treatment of Obsessive Compulsive Disorder
Principal Investigator(s): Wayne Goodman

Online Group Treatment of Emotional Dyscontrol
Principal Investigator(s): Jason Krellman

Cortical-Subcortical Interaction in Parkinson’s Disease
Principal Investigator(s): Kristina Simonyan, M.D., Ph.D.

Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia and Other Focal Dystonias
Principal Investigator(s): Kristina Simonyan

Efficacy of Simultaneous Intraparenchymal and Ventricular Intracranial Pressure Monitoring at the Same Site
Principal Investigator(s): Ullman, Jamie S.

Computerized cognitive intervention in the oldest-old: A feasibility study
Principal Investigator(s): Michal Schnaider-Beeri

Framing Eighteen Coils in Cerebral Aneurysm Trial (FEAT)
Principal Investigator(s): Johanna Fifi

ADAPT: A Comparison of Direct Aspiration vs Stent Retriever As a First Approach
Principal Investigator(s): J Mocco

A Phase IIIb, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Alteplase in Patients with Mild Stroke: Rapidly Improving Symptoms and Minor Neurological Deficits (PRISMS)
Principal Investigator(s): Aaron Tansy

Late Effects of Traumatic Brain Injury
Principal Investigator(s): Wayne Gordon

Reclaim Deep Brain Stimulation Therapy for Obsessive-Compulsive Disorder
Principal Investigator(s): Goodman, Wayne

Effects of Early-Life Stress on Brain Dysfunction in HIV+ Adults (Project STRIVE)
Principal Investigator(s): Uraina Clark

An open-label, 12 months safety and efficacy study of Levodopa- carbidopa intestinal gel in levodopa-responsive subjects with advanced parkinson's disease and severe motor-fluctuations despite optimized treatment with available parkinson's disease medications
Principal Investigator(s): Cho, Catherine

Behavioral and fMRI studies of cognition in healthy individuals and patients with anxiety
Principal Investigator(s): Emily Stern

The NeuroTouch Simulation Study
Principal Investigator(s): Joshua Bederson

A Randomized Multicenter Clinical Trial of Unruptured Brain Arteriovenous malformations (ARUBA)
Principal Investigator(s): Moskowitz, Alan

Retrospective Review of Cerebral Aneurysms Treated via Coil Embolization
Principal Investigator(s): Johanna Fifi , MD

Is Sct02 dependent on patient position?
Principal Investigator(s): Fischer, Gregory W.

Brain sensorimotor reorganization as a predictor of clinical outcome following laryngectomy
Principal Investigator(s): Kristina Simonyan

The TOMMORROW Study: A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Simultaneously Qualify a Biomarker Algorithm for Prognosis of Risk of Developing Mild Cognitive Impairment due to Alzheimer's Disease (MCI due to AD) and to Test the Safety and Efficacy of Pioglitazone (AD-4833 SR 0.8 mg QD) to Delay the Onset of MCI due to AD in Cognitively Normal Subjects
Principal Investigator(s): Judith Neugroschl

Onabotulinumtoxina for the treatment of new daily persistent headache: an open label study
Principal Investigator(s): Adelene Jann